Early oral contraceptive history: norethynodrel is not a prohormone
Edgren, R.A.
Steroids 59(1): 58-59
1994
ISSN/ISBN: 0039-128X PMID: 8140604 DOI: 10.1016/0039-128x(94)90047-7Document Number: 479183
Document emailed within 0-6 h
Related Documents
Marks, L. 1999: Human guinea pigs? The history of the early oral contraceptive clinical trials - Des cobayes humains? L'histoire des essais cliniques de contraception par voie orale History and Technology 15(4): 263-288Marks, L. 1999: Human guinea pigs? The history of the early oral contraceptive clinical trials - Des cobayes humains? L'histoire des essais cliniques de contraception par voie orale History and Technology 15(4): 263-288
Heinemann, L.A.J.; Lewis, M.A.; Kuhlhabich, D.; Braendle, W.; Moehner, S.; G C, E.M.A.N.N. L.A.J. 2002: The risk of breast tumours and lifetime history of oral contraceptive use Geburtshilfe und Frauenheilkunde 62(8): 750-757
Modugno, F.; Ness, R.B.; Allen, G.O.; Schildkraut, J.M.; Davis, F.G.; Goodman, M.T. 2004: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis American Journal of Obstetrics and Gynecology 191(3): 733-740
Bird, J.L.; Oinonen, K.A. 2011: Elevated eating disorder symptoms in women with a history of oral contraceptive side effects Archives of Women's Mental Health 14(4): 345-353
Huzell, L.; Persson, M.; Simonsson, M.; Markkula, A.; Ingvar, C.; Rose, C.; Jernström, H. 2015: History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response Breast Cancer Research and Treatment 149(2): 505-515
Davidson, B.A.; Moorman, P.G. 2014: Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer Expert Opinion on Drug Safety 13(10): 1375-1382
Miller, D.R.; Rosenberg, L.; Kaufman, D.W.; Schottenfeld, D.; Stolley, P.D.; Shapiro, S. 1986: Breast cancer risk in relation to early oral contraceptive use Obstetrics and Gynecology 68(6): 863-868
Rushton, L.; Jones, D.R. 1992: Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use British Journal of Obstetrics and Gynaecology 99(3): 239-246
Kaul, L.; Ahluwalia, B. 1978: Interrelation of caffeine and oral contraceptive steroid metabolism in hypertensive oral contraceptive users in humans Journal of Steroid Biochemistry 9(9): 862-863
Walker, G.R.; Schlesselman, J.J.; Ness, R.B. 2002: Family history of cancer, oral contraceptive use, and ovarian cancer risk American Journal of Obstetrics and Gynecology 186(1): 8-14
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49
Olsson, H.; Borg, A.; Fernö, M.; Möller, T.R.; Ranstam, J. 1991: Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden Cancer Detection and Prevention 15(4): 265-271
Spangler, L.; Ichikawa, L.E.; Hubbard, R.A.; Operskalski, B.; LaCroix, A.Z.; Ott, S.M.; Scholes, D. 2015: A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women Annals of Epidemiology 25(1): 55-59
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Audet, M.C.; Moreau, M.; Koltun, W.D.; Waldbaum, A.S.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial JAMA 285(18): 2347-2354
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Mansour, D.; Verhoeven, C.; Sommer, W.; Weisberg, E.; Taneepanichskul, S.; Melis, G.B.; Sundström-Poromaa, I.; Korver, T. 2011: Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 430-443